Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 7246 AL 7260

MRI protocols and sequences for amyloid-related imaging abnormalities monitoring in Alzheimer's disease patients treated with monoclonal antibodies

Agosta F, Cecchetti G, Spinelli EG, Ghirelli A, Rugarli G, Filippi M.

Curr Opin Neurol. 2025 Aug 1;38(4):289-297. doi: 10.1097/WCO.0000000000001388. Epub 2025 Jun 4.

Bioactive compound nanoparticles for Alzheimer's disease

Kshirsagar N, Patil A, Suryawanshi M.

Inflammopharmacology. 2025 Jun;33(6):2963-2976. doi: 10.1007/s10787-025-01801-2. Epub 2025 Jun 5.

Interlinking diabetes and Alzheimer's disease: A pathway through medicinal plant-based treatments

Pattanaik SK, Anil PM, Jena S, Rath D.

J Ethnopharmacol. 2025 Jul 24;351:120092. doi: 10.1016/j.jep.2025.120092. Epub 2025 Jun 6.

Alzheimer's Disease: A Review of Molecular Mechanisms and Therapeutic Implications by Targeting Sirtuins, Caspases, and GSK-3

Pandya K, Roul K, Tripathi A, Belemkar S, Sinha A, Erol M, Kumar D.

ACS Chem Neurosci. 2025 Jun 18;16(12):2178-2195. doi: 10.1021/acschemneuro.5c00207. Epub 2025 Jun 9.

Proposed Therapeutic Strategy to Combat Alzheimer's Disease by Targeting Beta and Gamma Secretases

Kumar D, Anand P, Singh SK.

Curr Alzheimer Res. 2025;22(5):344-358. doi: 10.2174/0115672050380899250602042028.

The role of the oral microbiome, host response, and periodontal disease treatment in Alzheimer's disease: A primer

Chalmers JC, Hernandez-Kapila YL.

Periodontol 2000. 2025 Jun;98(1):220-227. doi: 10.1111/prd.12631. Epub 2025 Jun 11.

Tirzepatide: a novel therapeutic approach for Alzheimer's disease

Alshehri GH, Al-Kuraishy HM, Waheed HJ, Al-Gareeb AI, Faheem SA, Alexiou A, Papadakis M, El-Saber Batiha G.

Metab Brain Dis. 2025 Jun 11;40(5):221. doi: 10.1007/s11011-025-01649-z.

Role of quinoline and indole-based heterocycles in revolutionizing Alzheimer's drug discovery: Promising futuristic structural designs

Dorababu A.

J Pharmacol Exp Ther. 2025 Jul;392(7):103606. doi: 10.1016/j.jpet.2025.103606. Epub 2025 May 14.

Targeting Acetylcholinesterase with Oxytocin: A New Avenue in Alzheimer's Disease Therapeutics

Danta CC, Chaudhari P, Nefzi A.

ACS Chem Neurosci. 2025 Jul 2;16(13):2336-2339. doi: 10.1021/acschemneuro.5c00383. Epub 2025 Jun 17.

Multi-Target Drug Design in Alzheimer's Disease Treatment: Emerging Technologies, Advantages, Challenges, and Limitations

Hossain MS, Hussain MH.

Pharmacol Res Perspect. 2025 Aug;13(4):e70131. doi: 10.1002/prp2.70131.

Histone deacetylase 6 inhibitors in Alzheimer's disease therapy: structure design and challenges

Dang B, Chen H, Liu S, Liu H, Kang Z, Yang Z, Yang W, Hu J, Chen X.

Bioorg Med Chem Lett. 2025 Nov 1;127:130318. doi: 10.1016/j.bmcl.2025.130318. Epub 2025 Jun 26.

Therapeutic and clinical potential of thiolutin microneedles on Alzheimer's disease mitigation

Khan GJ, Malik AM.

Int J Pharm. 2025 Sep 15;682:125898. doi: 10.1016/j.ijpharm.2025.125898. Epub 2025 Jun 27.

An overview of the rivastigmine 13.3 mg/24h transdermal patch as a treatment option for Alzheimer's disease

Fortea J, Ferrer-Picón E.

Expert Rev Neurother. 2025 Sep;25(9):1119-1129. doi: 10.1080/14737175.2025.2527211. Epub 2025 Jul 3.

Heat shock proteins regulates Tau protein aggregation in Alzheimer's disease

Chinnathambi S.

Adv Protein Chem Struct Biol. 2025;146:161-178. doi: 10.1016/bs.apcsb.2024.08.003. Epub 2024 Sep 11.

Unravelling the Alzheimer's pathogenesis: Molecular and cellular pathways to neurodegeneration and therapeutic targets

Chauhan P, Wadhwa K, Singh G.

Pathol Res Pract. 2025 Aug;272:156109. doi: 10.1016/j.prp.2025.156109. Epub 2025 Jul 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias